(Q28194897)

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Measures of early postoperative mortality: beyond hospital fatality rates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Prevention of venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Postthrombotic syndrome after hip or knee arthroplasty: a cross-sectional study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Incidence of venous thromboembolism in hospitalized patients vs community residents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Prognosis of Cancers Associated with Venous Thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Elevated C-reactive protein levels in overweight and obese adults

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Early Inpatient Rehabilitation After Elective Hip and Knee Arthroplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

The bleeding severity index: validation and comparison to other methods for classifying bleeding complications of medical therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

The effect of early weight-bearing on the stability of femoral neck fractures treated with Knowles pins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Cost effectiveness of accelerated rehabilitation after proximal femoral fracture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Venous thromboembolic disease after hybrid hip arthroplasty with negative duplex screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

What is the role of timing in the surgical and rehabilitative care of community-dwelling older persons with acute hip fracture?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Elastic stockings in the prevention of pulmonary embolism; a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Graduated compression stockings in the prevention of postoperative deep vein thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

The efficacy of graduated compression stockings in the prevention of deep vein thrombosis after major gynaecological surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Prevention of deep vein thrombosis in potential neurosurgical patients. A randomized trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression with control.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Elastic compression in the prevention of venous stasis. A critical reevaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Graded compression stockings in elective orthopaedic surgery. An assessment of the in vivo performance of commercially available stockings in patients having hip and knee arthroplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

The efficacy of graduated compression stockings in the prevention of deep vein thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Effects of external pneumatic intermittent compression on fibrinolysis in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

External pneumatic compression and fibrinolysis in abdominal surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Intermittent pneumatic calf compression for prevention of deep venous thrombosis in general abdominal surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Comparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

A randomized trial of low-dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

A comparison of intermittent calf compression and enoxaparin for thromboprophylaxis in total hip replacement. A pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

A meta-analysis of methods to prevent venous thromboembolism following total hip replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Management of anticoagulation before and after elective surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

The Tempofilter: a multicenter study of a new temporary caval filter implantable for up to six weeks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Günther Tulip Retrievable Vena Cava Filter: results from the Registry of the Canadian Interventional Radiology Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Starting prophylaxis for venous thromboembolism postoperatively

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Prophylactic agents for venous thrombosis in elective hip surgery. Meta-analysis of studies using venographic assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Management and dosing of warfarin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

FDA public health advisory.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Low-dose heparin thromboembolism prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Deep venous thrombosis: a continuing problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Prolonged prophylaxis in postoperative medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Incidence and prevention of deep venous thrombosis occurring late after general surgery: randomised controlled study of prolonged thromboprophylaxis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Cost-effectiveness of prophylactic anticoagulation prolonged after hospital discharge following general surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Efficacy and cost of low-molecular-weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Low-molecular-weight heparin versus warfarin for secondary prophylaxis of venous thromboembolism: a cost-effectiveness analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Asymptomatic patients at high risk for deep venous thrombosis who receive inadequate prophylaxis should be screened

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Surveillance venous scans for deep venous thrombosis in multiple trauma patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

The management of anticoagulation before and after procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Perioperative management of the chronically anticoagulated patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Management of the anticoagulated patient for ophthalmic surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Warfarin and cataract extraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Laparoscopic cholecystectomy in anticoagulated patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Transurethral resection of the prostate and bladder tumour without withdrawal of warfarin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Hemorrhage following colonoscopic polypectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Gastroenterological procedures among patients with disorders of hemostasis: evaluation and management recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Dental surgery in anticoagulated patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Simple and safe method to prepare patients with prosthetic heart valves for surgical dental procedures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Perioperative anticoagulant control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Management and prognosis of life-threatening bleeding during warfarin therapy. National Consortium of Anticoagulation Clinics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

The Long-Term Clinical Course of Acute Deep Venous Thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Rebound after cessation of oral anticoagulant therapy: the biochemical evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

The management of anticoagulation during noncardiac operations in patients with prosthetic heart valves. A prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Recurrent systemic embolic events with valve prosthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

7 January 2021

Prosthetic heart valves

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Anticoagulation for noncardiac procedures in patients with prosthetic heart valves. Does low risk mean high cost?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Use of enoxaparin for the chronically anticoagulated patient before and after procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Dalteparin as periprocedure anticoagulation for patients on warfarin and at high risk of thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Pulmonary embolism as a cause of death. The changing mortality in hospitalized patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

A prospective study of venous thromboembolism after major trauma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Silent deep vein thrombosis in immobilized multiple trauma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Temporary discontinuation of warfarin therapy: changes in the international normalized ratio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900144-X